Navigation Links
New strategies with greater antitumorous efficacy
Date:10/2/2007

One of the biggest problems in the current treatment of cancer is that the agents that are efficacious in the destruction of tumorous cells are, at the same time, extremely toxic for the rest of the healthy cells and tissues of the patient. To address the problem the University of the Basque Country (UPV/EHU) is seeking more specific treatments and studying the differences between tumorous cells and healthy ones.

A research team from the Faculty of Medicine and Odontology is working on identifying pharmacological agents that increase the therapeutic benefit of combinations of chemo-, immune and radiotherapy agents in the treatment of cancer ailments.

The aim of the research team was to identify compounds that act on the metabolic pathways and processes that take place differently depending whether a diseased tissue of a patient or healthy tissue is involved; in this way selective action can be undertaken, increasing the sensitivity of treatments for diseased tissues without damaging healthy cells or tissues at the same time.

With this general goal the researchers tested various biomodulators on a number of different tumorous modules such as melanoma, sarcoma and cancer of the colon. On the one hand, they studied agents that modulated levels of glutathione (GSH) key element in the biological processes of cells, both healthy and tumorous. Tumorous cells with high GSH levels have a greater growth and metastatic capacity and a lower sensitivity to antitumorous agents. On the other hand, one of the features of tumorous cells is that they lose their normal level of differentiation and, instead of exercising a determined function, they start to proliferate and generate a greater quantity of tumorous cells. This is why the researchers have also used agents that induce differentiation, such as are retinoids.

More selective therapies

Both groups of modulators have been associated with classic agents used in antitumorous the
'/>"/>

Contact: Irati Kortabitarte
iratik@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Research on causes for falling helps develop preventive strategies
2. Strategies That Might Lower Blood Pressure Questioned
3. New Strategies For Effective Treatment Of Malaria
4. Experts State Strategies To Increase Good Cholesterol
5. Strategies to prevent the rising tide of the epidemic of chronic diseases
6. Vitamin A supplementation inadequate in India: Need for effective strategies
7. Strategies To Boost Living Donor Kidney Transplants
8. Japan planning Strategies to combat Bird flu
9. Need of the Hour: Viable Strategies against AIDS
10. Kellogg Warned Against Its Marketing Strategies
11. India to Spend Rs.10 bn on Polio Eradication Strategies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...RNewswire-FirstCall/ -- Watson Pharmaceuticals, In...leted the acquisition of Arrow Group for a combina...ancially strong, global specialty pharmaceutical c... operations in more than 20 countries. ,, "The...eholders as a result of this financially smart tra...
(Date:12/2/2009)...B, not Addison,s, researcher says , , W...ind Pride and Prejudice and Emma may have die...s has long been believed, says one British scholar...e of 41, many historians and other experts have be...cts the adrenal glands and creates problems with b...
(Date:12/2/2009)...k prior to pregnancy increased risk by 22% , ... who drink five or more servings of sugar-sweetene...r risk of developing diabetes during pregnancy, a ...hown an association with other chronic metabolic p...istant professor of epidemiology at Louisiana Stat...
(Date:12/2/2009)...es around the world will join together for the 13t...Sunday, December 13 to remember all children who d...be held in the United States and around the globe ...candle lighting. , Oak Br...ds of families around the world, grieving the loss...
(Date:12/2/2009)...Newswire/ -- ,, Expert Panel to Discuss Scree...pecial press briefing will be held Wednesday, Dec....panel of top experts who will discuss the recent U...e of revised screening mammography guidelines. Man...ts and government authorities dispute the guidelin...
Breaking Medicine News(10 mins):Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5Health News:New Light on Jane Austen's Final Chapter 2Health News:Sugary Colas Tied to Gestational Diabetes 2Health News:Sugary Colas Tied to Gestational Diabetes 3Health News:Bereaved Families Unite for Compassionate Friends Worldwide Candle Lighting 2Health News:Wednesday, Dec. 2: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Health News:Wednesday, Dec. 2: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3
...ree condoms for nearly 9 months will soon be provi.../ the New York city logo as a promotional offer. M...uted since June, according to health officials. ...r would materialise in the next couple of months. ...
...cted that by 2020 road accidents will be the third...c health issues like tuberculosis, diarrhoea and H...atalities are expected to increase from 135,000 in...n' released Tuesday. Around 85 percent of th...
...tival, hot air balloon festival for 2 weeks, inaug...as been the joint efforts of Rajasthan Tourism and...ling from 11countries are participating, who will ... hot air balloons, the locale of Rajasthan making ...
...on has been confirmed in Greece, Bulgaria and Sl...ve been initiated by the Italian following detecti... br> The EU confirmed that samples sent to its ...eece. A spokesman said that in keeping with E...
...ll condoms in school through installation of condo... largest political party in Australia.// Ka... Australia's state parliament, said the issue was ...they are certainly telling their friends. We can't...
...riage) is thought to bring an increased number of ...ge lead to betterment in the health of both sexes ...y couples also offer numerous advantages. Prof...alth said that such marriages apart from health be...
Other Medicine News:Health News:Road accidents greater threat than AIDS, TB: WHO 2
(Date:12/2/2009)...FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasd... Drug Administration (FDA) has granted Fast Track ...,s novel, potentially first-in-class, oral anti-ca...nase (PI3K)/Akt pathway, for the treatment of rela... Track program of the FDA is designed to facilitat...
(Date:12/2/2009)...RNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: C...for pathologists, oncologists and the pharmaceutic...icer transition plan that calls for veteran financ...enior Vice President and Chief Financial Officer o...urrent Senior Vice President and Chief Financial O...
(Date:12/1/2009)..., Germany, Dec. 1 Matrox Graphics ...hics solutions, is pleased to announce that FUJIFI...M) Series display controller boards in several of...film Synapse. ,, Fujifilm is one of the leadin...g the world,s first internet-based PACS (SYNAPSE) ...
Breaking Medicine Technology:Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Clarient Announces CFO Transition Plan 2Clarient Announces CFO Transition Plan 3Clarient Announces CFO Transition Plan 4FUJIFILM Europe Teams Synapse with Matrox Xenia 2FUJIFILM Europe Teams Synapse with Matrox Xenia 3Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 1Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 2Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 3Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 4Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 5Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 6Winners Announced in 2009 Collegiate Inventors Competition 28R 29 14564 7Accuray Announces Regionalized Management Strategy for Americas 5647 1Accuray Announces Regionalized Management Strategy for Americas 5647 2Accuray Announces Regionalized Management Strategy for Americas 5647 3Ikaria Receives Award for Excellence by New Jersey Business 26amp 3B Industry Association 5642 1Ikaria Receives Award for Excellence by New Jersey Business 26amp 3B Industry Association 5642 2
... Nov. 20 Duska Therapeutics,Inc., (OTC Bulletin B... its,pivotal Phase 3 ATPace clinical trial protoco...SPA) procedure with the U.S. Food and Drug Adminis...ement with the FDA, Duska intends to initiate a,si...d and randomized Phase 3,clinical trial with its l...
... Clinical data from a prospective,registry presen...hows DVT,treatment with the Trellis(R) Peripheral ... Clara, CA) successfully breaks up the blood clot ... technique, called isolated pharmacomechanical thr...fely than current catheter-directed thrombolysis,(...
Other Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3
CenterPointLock Large Drainable Pouch
CenterPointLock Drainable Mini-Pouch, White
CenterPointLock Cut-to-Fit FlexWear Skin Barrier, Flat
CenterPointLock Cut-to-Fit Flextend Skin Barrier, Convex
Medicine Products: